iShare Medical working with VA, Medicare, Medicaid to improve patient outcomes, reduce cost of care
July 3, 2019 | Michaela Kitchen
Medical errors shouldn’t be among the leading causes of death in a country as developed as the United States, said Linda Van Horn, especially when failure to communicate critical information across platforms is to blame.

Linda Van Horn, iShare Medical
“It’s unacceptable to make mistakes, just because the information is not readily available to the provider, the doctor or the hospital at the point of care,” said Van Horn, founder of iShare Medical. “They’re having to make decisions on incomplete information.”
Kansas City-based iShare Medical specializes in an electronic healthcare record (EHR) combining medical data from across practices to allow physicians in different offices to review a patient’s full medical history. The streamlined system is intended to improve patient outcomes and reduce costs.
The startup has so quickly been accepted across the healthcare industry that it already works with more than 20 agencies, including Medicare, Medicaid and the Veterans Affairs system. iShare Medical is one of only five accredited government trust anchors in the U.S., said Van Horn.
“We spend nearly $4 trillion annually on health care, and half of that is spent by the federal government,” she said. “If we could just achieve a 20 or 25 percent cut in costs of healthcare, we could achieve significant savings.”
Click here to learn more about iShare Medical.
Errant medical care frequently isn’t caused by neglect on the part of a doctor, Van Horn said, citing a study by Johns Hopkins Hospital that noted such deaths, “represent systemic problems, including poorly coordinated care [and] fragmented insurance networks.”

Linda Van Horn, iShare Medical, InvestMidwest
Analog practices like faxing medical records between offices contribute to potentially deadly or overly costly patient care, wherein information can more easily be lost, misread or misinterpreted, she said.
“And because we don’t have the accurate medical record, we end up repeating tests and doing more encounters, and spending more money because we don’t have all the information at our fingertips,” Van Horn said.
Additionally, patients might have forgotten about previous surgeries, conditions or exam results, she said, posing significant, unintended risks when doctors essentially enter a situation blind to a person’s actual medical history.
Eliminating such confusion with a platform like iShare Medical offers life-saving potential, Van Horn said.
“It makes the system more efficient, more accurate, which reduces costs, improves care and outcomes and ultimately saves lives,” she said. “It is unacceptable that the third leading cause of death in the U.S. is preventable medical errors. That is staggering.”

2019 Startups to Watch
stats here
Related Posts on Startland News
Fortune 500 company says it’s bringing 2,000 jobs paying $100K to OP’s former Sprint campus
No better proof that ‘Kansas City has the capacity and competitiveness to meet this moment’ A globe-spanning fintech leader’s plan to create a new strategic hub in Overland Park is expected to include a $4 billion payroll investment in the Kansas City region over the next decade, the company said this week. Milwaukee-based Fiserv officially…
Mr K finalist reveal: Meet the 10 contenders for KC Chamber’s Small Business of the Year
The KC Chamber just announced the 10 finalists for its prestigious 2025 Small Business of the Year honor — setting the stage for a two-month campaign for selected entrepreneurs that ends this summer with one company crowned the Mr. K Award winner. “Small businesses remain the driving force of Kansas City’s economy, and we couldn’t…
USDA approves KC biotech startup’s secret weapon in the fight against cancer in dogs
Full USDA approval of a Kansas City startup’s bone cancer therapy for dogs reflects a more-than-decade-long commitment to improving the lives of pets and their families, said Tammie Wahaus, CEO of ELIAS Animal Health. The U.S. Department of Agriculture Center for Veterinary Biologics recently approved the first-in-class ELIAS Cancer Immunotherapy (ECI) treatment for canine osteosarcoma…
